The US company Pfizer said that the Corona virus vaccine was safe and produced strong antibody responses in children aged 5 to 11 years in a large-scale trial, results that could pave the way to start vaccinating school children within months..
Corona vaccine for children
And according to a Bloomberg report, the long-awaited results provide one of the first looks at how well the coronavirus vaccine works with younger children..
In a trial with 2,268 participants, two doses of FERZ-10 micrograms – one third of the adult dose – achieved high levels of antibodies, similar to those seen in the 16 to 25-year-old adult trial who got the whole.
She said two companies Pfizer And BioNTech They plan to send the data as part of a near-term application for emergency use authorization from the US Food and Drug Administration, and share it with regulators in Europe as well..
